Back to Search
Start Over
[Therapeutic regimens using monoclonal antibodies in gastroenterology]
- Source :
- Der Internist. 60(10)
- Publication Year :
- 2019
-
Abstract
- Therapeutic regimens using monoclonal antibodies have been implemented in clinical daily practice for various gastroenterological diseases, for therapeutic strategies in gastrointestinal (GI) oncology, and infectious diseases of the gastrointestinal tract. The main indications remain the therapy of chronic inflammatory bowel disease and in GI oncology. A new field has opened for targeted therapy with monoclonal antibodies of recurrent Clostridium difficile infection. In the nomenclature of monoclonal antibodies, the endings of the substances indicate the production or degree of "humanization" of the respective antibodies ("umab": fully human, recombinant antibody; "ximab": chimeric antibody with variable murine domain). For chronic inflammatory bowel disease, monoclonal antibodies has been developed to interfere with molecular targets of the inflammatory cascade in the underlying pathogenesis (tumor necrosis factor‑α, interleukin-12 and -23; α4β7-integrins). The development of targeted therapies in the treatment of GI malignancies, monoclonal antibodies has been developed to interfere with substantial pathways of proliferation and apoptosis as well as neoplastic vascularization and neovascularization (e.g., vascular endothelial growth factor [VEGF] and VEGF receptor antibodies, epidermal growth factor receptor antibodies, HER2/neu antibodies). In the current review, we provide a summary of the current applications of monoclonal antibodies in the therapeutic treatment of gastroenterological diseases.
- Subjects :
- Vascular Endothelial Growth Factor A
Gastrointestinal Diseases
Gastroenterology
Antibodies, Monoclonal
Inflammatory Bowel Diseases
ErbB Receptors
Mice
Antineoplastic Agents, Immunological
Receptors, Vascular Endothelial Growth Factor
Crohn Disease
Stomach Neoplasms
Animals
Humans
Immunologic Factors
Colitis, Ulcerative
Molecular Targeted Therapy
Colorectal Neoplasms
Subjects
Details
- Language :
- German
- ISSN :
- 14321289
- Volume :
- 60
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Der Internist
- Accession number :
- edsair.pmid..........d3d0b03f7aaee609e744801ecc38160d